Buscar en
Archivos de la Sociedad Española de Oftalmología (English Edition)
Toda la web
Inicio Archivos de la Sociedad Española de Oftalmología (English Edition) Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ...
Journal Information
Vol. 87. Issue 5.
Pages 153-156 (May 2012)
Share
Share
Download PDF
More article options
Visits
1577
Vol. 87. Issue 5.
Pages 153-156 (May 2012)
Short communication
Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ranibizumab: A report of two cases
Neovascularización coroidea secundaria a seudoxantoma elástico tratada con ranibizumab: a propósito de dos casos
Visits
1577
A. González-Gómez
Corresponding author
anagg_82@hotmail.com

Corresponding author.
, M.J. Morillo, A.B. González-Escobar, J.M. García-Campos
Servicio de Oftalmología, Hospital Universitario Virgen de la Victoria, Málaga, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Abstract
Case report

We report two cases of pseudoxanthoma elasticum with angioid streaks and choroidal neovascularization (CNV) in both eyes. Intravitreal ranibizumab (Lucentis) was administered with successful results in both cases.

Discussion

CNV has been reported to occur in 72–86% of patients with angioid streaks. Although uncommon, the impact of CNV is important because it tends to affect people of working age. Based on the effectiveness of ranibizumab in other secondary CNVs, we decided to use it in our patients, observing the functional and anatomical improvement.

Keywords:
Angioid streaks
Ranibizumab
Choroidal neovascularization
Pseudoxanthoma elasticum
Resumen
Caso clínico

Se presentan dos pacientes diagnosticados de pseudoxantoma elástico (PXE), que presentaban estrías angioides (EA) en ambos ojos y neovascularización coroidea (NVC) secundaria de manera unilateral. Ambos fueron tratados con inyecciones intravítreas de ranibizumab (Lucentis), obteniendo una respuesta favorable en ambos casos.

Discusión

La NVC afecta al 72-86% de los pacientes con estrías angioides. Es una patología poco frecuente pero importante, ya que se presenta en pacientes con vida laboral activa. Se decidió emplear este tratamiento teniendo en cuenta la efectividad del ranibizumab en NVC secundarias a otras patologías, observando la mejoría anatómica y funcional del cuadro.

Palabras clave:
Estrías angioides
Ranibizumab
Neovascularización coroidea
Seudoxantoma elástico

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de la Sociedad Española de Oftalmología (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos